Abcuro

About:

Abcuro develops immunotherapies to treat autoimmunity and cancer.

Website: http://www.abcuro.com

Twitter/X: AbcuroInc

Top Investors: BlackRock, RA Capital Management, Samsara BioCapital, Bain Capital Life Sciences, New Leaf Ventures

Description:

Abcuro’s mission is to develop immune-modulatory bio-therapeutics for treating both autoimmunity and cancer. They leverage the systematic target validation and clinical insights gained by their founders to identify new targets. Their intensive use of bioinformatics to interrogate the transcriptome of human disease together with ex-vivo validation in diseased tissue has uncovered new approaches to target key compartments of the immune system.